Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Medmonitor

83 posts found

Medmonitor

Walmart Recalls Supplement for Joint Pain Due to Hidden Drug Ingredients

Artri Ajo King contains undeclared diclofenac, creating safety concerns.

Medmonitor

FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

Medmonitor

Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.

Medmonitor

FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

Medmonitor

FDA Issues Warning for Dental Problems with Dissolvable Buprenorphine Products

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

Medmonitor

FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

Medmonitor

COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Medmonitor

FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

Medmonitor

New Drugs, Generics, and a COVID-19 Treatment Update

A new migraine medication, various generics, and more.

Medmonitor

FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

Medmonitor

New Generic Approvals

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

Medmonitor

FDA and CDC: Vaccinated Adults Will Not Need COVID-19 Booster Shots

A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.

Medmonitor

FDA Approves First New Weight Loss Drug Since 2014, Issues EUA for COVID-19 Antibody

Wegovy (semaglutide) and sotrovimab will soon be available.

Medmonitor

FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.

Medmonitor

FDA and CDC Recommend Resuming Use of Johnson & Johnson COVID-19 Vaccine

After reviewing six rare cases of blood clots after 7 million doses, current data indicates the vaccine is safe.

Prev 1 2 3 4 5 6 Next

Workers' Comp Property and Casualty PBM
Expires 01/01/2028